Hepatitis C virus infection in Jeddah city, Saudi Arabia: Seroprevalence and knowledge

The infection rate of the hepatitis C virus (HCV) in Saudi Arabia is among the lowest in the world. However, it is likely that poor knowledge and awareness of HCV infection could minimize the effectiveness of prevention and control programs in the kingdom. Thus, the study objective was to estimate t...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of medical virology 2018-03, Vol.90 (3), p.526-531
Hauptverfasser: Al‐Raddadi, Rajaa M., Dashash, Noha A., Alghamdi, Hani A., Al‐Raddadi, Zeyad M., Alzahrani, Hanan S., Alsahafi, Abdullah J., Algarni, Abdullah M., Alghamdi, Majed M., Hakim, Raghad F., Al‐Zalabani, Abdulmohsen H., Hakim, Fanar, Moria, Feras A.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 531
container_issue 3
container_start_page 526
container_title Journal of medical virology
container_volume 90
creator Al‐Raddadi, Rajaa M.
Dashash, Noha A.
Alghamdi, Hani A.
Al‐Raddadi, Zeyad M.
Alzahrani, Hanan S.
Alsahafi, Abdullah J.
Algarni, Abdullah M.
Alghamdi, Majed M.
Hakim, Raghad F.
Al‐Zalabani, Abdulmohsen H.
Hakim, Fanar
Moria, Feras A.
description The infection rate of the hepatitis C virus (HCV) in Saudi Arabia is among the lowest in the world. However, it is likely that poor knowledge and awareness of HCV infection could minimize the effectiveness of prevention and control programs in the kingdom. Thus, the study objective was to estimate the prevalence of HCV infection, and to assess current knowledge about it, in the targeted population. Data on 5482 Saudi people attending primary healthcare centers in Jeddah City in 2014/2015 were analyzed in this cross‐sectional study. Questions that covered the natural history, risk behavior, and prevention, and treatment of HCV were collected using a predesigned questionnaire. HCV seroprevalence was assessed using an enzyme‐linked immunosorbent assay. HCV prevalence of 0.38% (95% confidence interval: 0.22‐0.54) was found. The level of knowledge of the natural history, risk behavior, and prevention and treatment of HCV was poor among the participants. The lowest level of knowledge for all participants pertained to its prevention and treatment. The prevalence of HCV was low in Saudi Arabia (0.38%). However, adequate knowledge of HCV was lacking. Thus, the need to increase knowledge and awareness of HCV in the Saudi population is warranted.
doi_str_mv 10.1002/jmv.24973
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1962423537</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1985656840</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3533-8a48d08b58fc19c30b636981c1171bb0d7c56d74c8f27e9cf1ab96687bce82583</originalsourceid><addsrcrecordid>eNp10D1PwzAQBmALgaB8DPwBZIkFJFJsJ3ZstqoCCgIx8LFGjn0BlzQpdlLUf4-hwIDEdDc8eu_0IrRPyZASwk6ns8WQZSpP19CAEiUSRXK6jgaEZiIRgvIttB3ClBAiFWObaIspwlLJ-QA9TWCuO9e5gMd44XwfsGsqMJ1rm7jha7BWv2DjuuUJvte9dXjkden0Gb4H3849LHQNjQGsG4tfm_a9BvsMu2ij0nWAve-5gx4vzh_Gk-Tm7vJqPLpJTMrTNJE6k5bIksvKUGVSUopUKEkNpTktS2Jzw4XNMyMrloMyFdWlEkLmpQHJuEx30NEqd-7btx5CV8xcMFDXuoG2DwVVgmUs3sojPfxDp23vm_hdVJILLmRGojpeKePbEDxUxdy7mfbLgpLis-will18lR3twXdiX87A_sqfdiM4XYF3V8Py_6Ti-vZpFfkBK3eHPg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1985656840</pqid></control><display><type>article</type><title>Hepatitis C virus infection in Jeddah city, Saudi Arabia: Seroprevalence and knowledge</title><source>Wiley Online Library Journals Frontfile Complete</source><creator>Al‐Raddadi, Rajaa M. ; Dashash, Noha A. ; Alghamdi, Hani A. ; Al‐Raddadi, Zeyad M. ; Alzahrani, Hanan S. ; Alsahafi, Abdullah J. ; Algarni, Abdullah M. ; Alghamdi, Majed M. ; Hakim, Raghad F. ; Al‐Zalabani, Abdulmohsen H. ; Hakim, Fanar ; Moria, Feras A.</creator><creatorcontrib>Al‐Raddadi, Rajaa M. ; Dashash, Noha A. ; Alghamdi, Hani A. ; Al‐Raddadi, Zeyad M. ; Alzahrani, Hanan S. ; Alsahafi, Abdullah J. ; Algarni, Abdullah M. ; Alghamdi, Majed M. ; Hakim, Raghad F. ; Al‐Zalabani, Abdulmohsen H. ; Hakim, Fanar ; Moria, Feras A.</creatorcontrib><description>The infection rate of the hepatitis C virus (HCV) in Saudi Arabia is among the lowest in the world. However, it is likely that poor knowledge and awareness of HCV infection could minimize the effectiveness of prevention and control programs in the kingdom. Thus, the study objective was to estimate the prevalence of HCV infection, and to assess current knowledge about it, in the targeted population. Data on 5482 Saudi people attending primary healthcare centers in Jeddah City in 2014/2015 were analyzed in this cross‐sectional study. Questions that covered the natural history, risk behavior, and prevention, and treatment of HCV were collected using a predesigned questionnaire. HCV seroprevalence was assessed using an enzyme‐linked immunosorbent assay. HCV prevalence of 0.38% (95% confidence interval: 0.22‐0.54) was found. The level of knowledge of the natural history, risk behavior, and prevention and treatment of HCV was poor among the participants. The lowest level of knowledge for all participants pertained to its prevention and treatment. The prevalence of HCV was low in Saudi Arabia (0.38%). However, adequate knowledge of HCV was lacking. Thus, the need to increase knowledge and awareness of HCV in the Saudi population is warranted.</description><identifier>ISSN: 0146-6615</identifier><identifier>EISSN: 1096-9071</identifier><identifier>DOI: 10.1002/jmv.24973</identifier><identifier>PMID: 29023855</identifier><language>eng</language><publisher>United States: Wiley Subscription Services, Inc</publisher><subject>Confidence intervals ; Control programs ; Enzyme-linked immunosorbent assay ; HCV ; Health care ; Health risk assessment ; Hepatitis ; Hepatitis C ; Infections ; Knowledge ; Prevention ; Risk taking ; Saudi Arabia ; Serology ; seroprevalence ; Virology ; Viruses</subject><ispartof>Journal of medical virology, 2018-03, Vol.90 (3), p.526-531</ispartof><rights>2017 Wiley Periodicals, Inc.</rights><rights>2018 Wiley Periodicals, Inc.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3533-8a48d08b58fc19c30b636981c1171bb0d7c56d74c8f27e9cf1ab96687bce82583</citedby><cites>FETCH-LOGICAL-c3533-8a48d08b58fc19c30b636981c1171bb0d7c56d74c8f27e9cf1ab96687bce82583</cites><orcidid>0000-0001-7102-629X ; 0000-0002-4937-6100</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1002%2Fjmv.24973$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1002%2Fjmv.24973$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,776,780,1411,27901,27902,45550,45551</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/29023855$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Al‐Raddadi, Rajaa M.</creatorcontrib><creatorcontrib>Dashash, Noha A.</creatorcontrib><creatorcontrib>Alghamdi, Hani A.</creatorcontrib><creatorcontrib>Al‐Raddadi, Zeyad M.</creatorcontrib><creatorcontrib>Alzahrani, Hanan S.</creatorcontrib><creatorcontrib>Alsahafi, Abdullah J.</creatorcontrib><creatorcontrib>Algarni, Abdullah M.</creatorcontrib><creatorcontrib>Alghamdi, Majed M.</creatorcontrib><creatorcontrib>Hakim, Raghad F.</creatorcontrib><creatorcontrib>Al‐Zalabani, Abdulmohsen H.</creatorcontrib><creatorcontrib>Hakim, Fanar</creatorcontrib><creatorcontrib>Moria, Feras A.</creatorcontrib><title>Hepatitis C virus infection in Jeddah city, Saudi Arabia: Seroprevalence and knowledge</title><title>Journal of medical virology</title><addtitle>J Med Virol</addtitle><description>The infection rate of the hepatitis C virus (HCV) in Saudi Arabia is among the lowest in the world. However, it is likely that poor knowledge and awareness of HCV infection could minimize the effectiveness of prevention and control programs in the kingdom. Thus, the study objective was to estimate the prevalence of HCV infection, and to assess current knowledge about it, in the targeted population. Data on 5482 Saudi people attending primary healthcare centers in Jeddah City in 2014/2015 were analyzed in this cross‐sectional study. Questions that covered the natural history, risk behavior, and prevention, and treatment of HCV were collected using a predesigned questionnaire. HCV seroprevalence was assessed using an enzyme‐linked immunosorbent assay. HCV prevalence of 0.38% (95% confidence interval: 0.22‐0.54) was found. The level of knowledge of the natural history, risk behavior, and prevention and treatment of HCV was poor among the participants. The lowest level of knowledge for all participants pertained to its prevention and treatment. The prevalence of HCV was low in Saudi Arabia (0.38%). However, adequate knowledge of HCV was lacking. Thus, the need to increase knowledge and awareness of HCV in the Saudi population is warranted.</description><subject>Confidence intervals</subject><subject>Control programs</subject><subject>Enzyme-linked immunosorbent assay</subject><subject>HCV</subject><subject>Health care</subject><subject>Health risk assessment</subject><subject>Hepatitis</subject><subject>Hepatitis C</subject><subject>Infections</subject><subject>Knowledge</subject><subject>Prevention</subject><subject>Risk taking</subject><subject>Saudi Arabia</subject><subject>Serology</subject><subject>seroprevalence</subject><subject>Virology</subject><subject>Viruses</subject><issn>0146-6615</issn><issn>1096-9071</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2018</creationdate><recordtype>article</recordtype><recordid>eNp10D1PwzAQBmALgaB8DPwBZIkFJFJsJ3ZstqoCCgIx8LFGjn0BlzQpdlLUf4-hwIDEdDc8eu_0IrRPyZASwk6ns8WQZSpP19CAEiUSRXK6jgaEZiIRgvIttB3ClBAiFWObaIspwlLJ-QA9TWCuO9e5gMd44XwfsGsqMJ1rm7jha7BWv2DjuuUJvte9dXjkden0Gb4H3849LHQNjQGsG4tfm_a9BvsMu2ij0nWAve-5gx4vzh_Gk-Tm7vJqPLpJTMrTNJE6k5bIksvKUGVSUopUKEkNpTktS2Jzw4XNMyMrloMyFdWlEkLmpQHJuEx30NEqd-7btx5CV8xcMFDXuoG2DwVVgmUs3sojPfxDp23vm_hdVJILLmRGojpeKePbEDxUxdy7mfbLgpLis-will18lR3twXdiX87A_sqfdiM4XYF3V8Py_6Ti-vZpFfkBK3eHPg</recordid><startdate>201803</startdate><enddate>201803</enddate><creator>Al‐Raddadi, Rajaa M.</creator><creator>Dashash, Noha A.</creator><creator>Alghamdi, Hani A.</creator><creator>Al‐Raddadi, Zeyad M.</creator><creator>Alzahrani, Hanan S.</creator><creator>Alsahafi, Abdullah J.</creator><creator>Algarni, Abdullah M.</creator><creator>Alghamdi, Majed M.</creator><creator>Hakim, Raghad F.</creator><creator>Al‐Zalabani, Abdulmohsen H.</creator><creator>Hakim, Fanar</creator><creator>Moria, Feras A.</creator><general>Wiley Subscription Services, Inc</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QL</scope><scope>7TK</scope><scope>7U9</scope><scope>8FD</scope><scope>C1K</scope><scope>FR3</scope><scope>H94</scope><scope>K9.</scope><scope>M7N</scope><scope>P64</scope><scope>RC3</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0001-7102-629X</orcidid><orcidid>https://orcid.org/0000-0002-4937-6100</orcidid></search><sort><creationdate>201803</creationdate><title>Hepatitis C virus infection in Jeddah city, Saudi Arabia: Seroprevalence and knowledge</title><author>Al‐Raddadi, Rajaa M. ; Dashash, Noha A. ; Alghamdi, Hani A. ; Al‐Raddadi, Zeyad M. ; Alzahrani, Hanan S. ; Alsahafi, Abdullah J. ; Algarni, Abdullah M. ; Alghamdi, Majed M. ; Hakim, Raghad F. ; Al‐Zalabani, Abdulmohsen H. ; Hakim, Fanar ; Moria, Feras A.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3533-8a48d08b58fc19c30b636981c1171bb0d7c56d74c8f27e9cf1ab96687bce82583</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2018</creationdate><topic>Confidence intervals</topic><topic>Control programs</topic><topic>Enzyme-linked immunosorbent assay</topic><topic>HCV</topic><topic>Health care</topic><topic>Health risk assessment</topic><topic>Hepatitis</topic><topic>Hepatitis C</topic><topic>Infections</topic><topic>Knowledge</topic><topic>Prevention</topic><topic>Risk taking</topic><topic>Saudi Arabia</topic><topic>Serology</topic><topic>seroprevalence</topic><topic>Virology</topic><topic>Viruses</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Al‐Raddadi, Rajaa M.</creatorcontrib><creatorcontrib>Dashash, Noha A.</creatorcontrib><creatorcontrib>Alghamdi, Hani A.</creatorcontrib><creatorcontrib>Al‐Raddadi, Zeyad M.</creatorcontrib><creatorcontrib>Alzahrani, Hanan S.</creatorcontrib><creatorcontrib>Alsahafi, Abdullah J.</creatorcontrib><creatorcontrib>Algarni, Abdullah M.</creatorcontrib><creatorcontrib>Alghamdi, Majed M.</creatorcontrib><creatorcontrib>Hakim, Raghad F.</creatorcontrib><creatorcontrib>Al‐Zalabani, Abdulmohsen H.</creatorcontrib><creatorcontrib>Hakim, Fanar</creatorcontrib><creatorcontrib>Moria, Feras A.</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Neurosciences Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Technology Research Database</collection><collection>Environmental Sciences and Pollution Management</collection><collection>Engineering Research Database</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Genetics Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of medical virology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Al‐Raddadi, Rajaa M.</au><au>Dashash, Noha A.</au><au>Alghamdi, Hani A.</au><au>Al‐Raddadi, Zeyad M.</au><au>Alzahrani, Hanan S.</au><au>Alsahafi, Abdullah J.</au><au>Algarni, Abdullah M.</au><au>Alghamdi, Majed M.</au><au>Hakim, Raghad F.</au><au>Al‐Zalabani, Abdulmohsen H.</au><au>Hakim, Fanar</au><au>Moria, Feras A.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Hepatitis C virus infection in Jeddah city, Saudi Arabia: Seroprevalence and knowledge</atitle><jtitle>Journal of medical virology</jtitle><addtitle>J Med Virol</addtitle><date>2018-03</date><risdate>2018</risdate><volume>90</volume><issue>3</issue><spage>526</spage><epage>531</epage><pages>526-531</pages><issn>0146-6615</issn><eissn>1096-9071</eissn><abstract>The infection rate of the hepatitis C virus (HCV) in Saudi Arabia is among the lowest in the world. However, it is likely that poor knowledge and awareness of HCV infection could minimize the effectiveness of prevention and control programs in the kingdom. Thus, the study objective was to estimate the prevalence of HCV infection, and to assess current knowledge about it, in the targeted population. Data on 5482 Saudi people attending primary healthcare centers in Jeddah City in 2014/2015 were analyzed in this cross‐sectional study. Questions that covered the natural history, risk behavior, and prevention, and treatment of HCV were collected using a predesigned questionnaire. HCV seroprevalence was assessed using an enzyme‐linked immunosorbent assay. HCV prevalence of 0.38% (95% confidence interval: 0.22‐0.54) was found. The level of knowledge of the natural history, risk behavior, and prevention and treatment of HCV was poor among the participants. The lowest level of knowledge for all participants pertained to its prevention and treatment. The prevalence of HCV was low in Saudi Arabia (0.38%). However, adequate knowledge of HCV was lacking. Thus, the need to increase knowledge and awareness of HCV in the Saudi population is warranted.</abstract><cop>United States</cop><pub>Wiley Subscription Services, Inc</pub><pmid>29023855</pmid><doi>10.1002/jmv.24973</doi><tpages>6</tpages><orcidid>https://orcid.org/0000-0001-7102-629X</orcidid><orcidid>https://orcid.org/0000-0002-4937-6100</orcidid></addata></record>
fulltext fulltext
identifier ISSN: 0146-6615
ispartof Journal of medical virology, 2018-03, Vol.90 (3), p.526-531
issn 0146-6615
1096-9071
language eng
recordid cdi_proquest_miscellaneous_1962423537
source Wiley Online Library Journals Frontfile Complete
subjects Confidence intervals
Control programs
Enzyme-linked immunosorbent assay
HCV
Health care
Health risk assessment
Hepatitis
Hepatitis C
Infections
Knowledge
Prevention
Risk taking
Saudi Arabia
Serology
seroprevalence
Virology
Viruses
title Hepatitis C virus infection in Jeddah city, Saudi Arabia: Seroprevalence and knowledge
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-05T19%3A59%3A22IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Hepatitis%20C%20virus%20infection%20in%20Jeddah%20city,%20Saudi%20Arabia:%20Seroprevalence%20and%20knowledge&rft.jtitle=Journal%20of%20medical%20virology&rft.au=Al%E2%80%90Raddadi,%20Rajaa%20M.&rft.date=2018-03&rft.volume=90&rft.issue=3&rft.spage=526&rft.epage=531&rft.pages=526-531&rft.issn=0146-6615&rft.eissn=1096-9071&rft_id=info:doi/10.1002/jmv.24973&rft_dat=%3Cproquest_cross%3E1985656840%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1985656840&rft_id=info:pmid/29023855&rfr_iscdi=true